S100A9 Exacerbates the A beta 1-42-mediated Innate Immunity in Human THP-1 Monocytes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jhang, Kyoung A. | - |
dc.contributor.author | Lee, Eun Ok | - |
dc.contributor.author | Kim, Hee-Sun | - |
dc.contributor.author | Chang, Keun-A | - |
dc.contributor.author | Suh, Yoo-Hun | - |
dc.contributor.author | Chong, Young Hae | - |
dc.date.available | 2020-02-28T06:43:10Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-09 | - |
dc.identifier.issn | 1871-5273 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9680 | - |
dc.description.abstract | The S100A9 protein is an important proinflammatory factor of innate immunity that has been proposed to participate in inflammation associated with the pathogenesis of Alzheimer's disease. Here, we provide insights into the potential roles of extracellular S100A9 in the interaction with the immune response in human THP-1 monocytic cells that have been challenged with amyloid beta 1-42 (A beta 1-42) monomers instead of oligomers. Extracellular S100A9 alone produced a stimulatory effect on tumor necrosis factor-alpha and interleukin-1 beta, expression as well as released monocyte chemoattractant protein-1 into culture supernatants, which was accompanied by an increased level of matrix metalloproteinas-9 activity. Importantly, co-stimulation with S100A9 and A beta 1-42 resulted in a marked enhancement of A beta 1-42-mediated release of these proinflammatory mediators under the same experimental conditions, whereas heat inactivated S100A9 had little effect. Our findings clearly suggest that excess S100A9 protein may play an important role in the pathological processes of Alzheimer's disease by exacerbating the A beta 1-42-induced innate immune response. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BENTHAM SCIENCE PUBL | - |
dc.relation.isPartOf | CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS | - |
dc.title | S100A9 Exacerbates the A beta 1-42-mediated Innate Immunity in Human THP-1 Monocytes | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000387121800006 | - |
dc.identifier.doi | 10.2174/1871527315666160815161922 | - |
dc.identifier.bibliographicCitation | CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, v.15, no.8, pp.910 - 917 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85010420347 | - |
dc.citation.endPage | 917 | - |
dc.citation.startPage | 910 | - |
dc.citation.title | CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS | - |
dc.citation.volume | 15 | - |
dc.citation.number | 8 | - |
dc.contributor.affiliatedAuthor | Chang, Keun-A | - |
dc.contributor.affiliatedAuthor | Suh, Yoo-Hun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | innate immunity | - |
dc.subject.keywordAuthor | S100A9 | - |
dc.subject.keywordPlus | AMYLOID PRECURSOR PROTEIN | - |
dc.subject.keywordPlus | MYELOID-RELATED PROTEINS | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | INFLAMMATORY S100A9 | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | ARTHRITIS | - |
dc.subject.keywordPlus | DECLINE | - |
dc.subject.keywordPlus | INJURY | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.